O
Oscotec Inc
KOSDAQ:039200
Oscotec Inc
KOSDAQ:039200
Price:
48 800
KRW
-8.1%
Market Closed
Market Cap:
₩1.9T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
O
|
Oscotec Inc
KOSDAQ:039200
|
KR |
|
F
|
FCW Holdings Bhd
KLSE:FCW
|
MY |
|
aTyr Pharma Inc
NASDAQ:ATYR
|
US |
|
M
|
MDC Holdings Inc
LSE:0JW5
|
US |
|
S
|
Stefanutti Stocks Holdings Ltd
JSE:SSK
|
ZA |
|
Rosseti Tsentr PAO
MOEX:MRKC
|
RU |
|
S
|
Savers Value Village Inc
NYSE:SVV
|
US |
|
Poligrafici Printing SpA
MIL:POPR
|
IT |
|
G
|
GeneralFinance SpA
MIL:GF
|
IT |
|
Nyfosa AB
STO:NYF
|
SE |
|
Hainan Jinpan Smart Technology Co Ltd
SSE:688676
|
CN |
|
V
|
Visual Photonics Epitaxy Co Ltd
TWSE:2455
|
TW |
|
Aspial Corporation Ltd
SGX:A30
|
SG |
|
Luoyang Northglass Technology Co Ltd
SZSE:002613
|
CN |
|
C
|
China Gold International Resources Corp Ltd
HKEX:2099
|
CA |
|
Kotobuki Spirits Co Ltd
TSE:2222
|
JP |
Multiples-Based Value
The Multiples-Based Value for Oscotec Inc (039200) under the Base Case is hidden KRW. Compared with the current market price of 48 800 KRW, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Oscotec Inc Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Oscotec Inc Competitors
Oscotec Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
O
|
Oscotec Inc
KOSDAQ:039200
|
1.9T KRW | 80.3 | -142.1 | -120.9 | -107.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD | 13.6 | 42.8 | 28.9 | 30.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD | 6.2 | 21.8 | 15.2 | 18.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.4 | 31.2 | 17.2 | 24.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.6 | 16.4 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.4 | 21.8 | 13.5 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD | 2.6 | 20.7 | 7.9 | 10.5 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD | 2.5 | 17 | 7.2 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
